Insights provides context and perspective about key pharmacy trends and issues

Cost Management
Multiple Sclerosis is a $19 billion market worldwide, and the third most expensive specialty drug spend category. Recently approved Ocrevus is likely to add to cost of treatment and needs... More
Briefing
Public Policy
Lowering out-of-pocket consumer costs, ending manipulation and abuse of FDA regulations, and fostering greater competition can help lower high prescription drug costs More
Commentary
Specialty
The specialty pipeline has many promising new drugs. The complexity and personalized nature of some medications require that they be managed under the medical benefit. More
Briefing
Public Policy
House Republicans passed their version of a new health care law, but the Senate version is likely to be very different. A replacement for ACA may take some time. More
Commentary
Cost Management
Limiting pharmaceutical sales activities at academic medical centers can help make a meaningful difference in prescribing patterns, and help reduce drug spend. More
Briefing
Care Management
Opioid abuse is a deadly epidemic. Measures such as proper disposal of medication and utilization management programs can help prevent and reduce drug abuse. More
Commentary
Pharmacy Innovation
Helping clients deliver affordable, accessible and effective care. More
Video
Troy Brennan
Cost Management
The current economics of health care are unsustainable and change is critical. More
Video
Specialty
The specialty pharmaceutical market continues to grow as a percentage of the overall prescription drug market, and its impact on payor trend also is rising. More
Feature
Drug Pipeline
Key drugs to watch for in the specialty pharmacy pipeline Q2-Q3 2017 More
Specialty Report